Literature DB >> 12151487

Relations between desire for early death, depressive symptoms and antidepressant prescribing in terminally ill patients with cancer.

E Tiernan1, P Casey, C O'Boyle, G Birkbeck, M Mangan, L O'Siorain, M Kearney.   

Abstract

Some patients with advanced cancer express the wish for an early death. This may be associated with depression. We examined the relations between depressive symptoms and desire for early death (natural or by euthanasia or physician-assisted suicide) in 142 terminally ill patients with cancer being cared for by a specialist palliative care team. They completed the Hospital Anxiety and Depression Scale questionnaire and answered four supplementary questions on desire for early death. Only 2 patients expressed a strong wish for death by some form of suicide or euthanasia. 120 denied that they ever wished for early release. The desire for early death correlated with depression scores. Depressive symptoms were common in the whole group but few were on antidepressant therapy. Better recognition and treatment of depression might improve the lives of people with terminal illness and so lessen desire for early death, whether natural or by suicide.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151487      PMCID: PMC1279962          DOI: 10.1177/014107680209500803

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  30 in total

1.  Suicide, assisted suicide, and medical illness.

Authors:  H Hendin
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

2.  Measuring desire for death among patients with HIV/AIDS: the schedule of attitudes toward hastened death.

Authors:  B Rosenfeld; W Breitbart; K Stein; J Funesti-Esch; M Kaim; S Krivo; M Galietta
Journal:  Am J Psychiatry       Date:  1999-01       Impact factor: 18.112

3.  Successful antidepressant treatment for five terminally ill cancer patients with major depression, suicidal ideation and a desire for death.

Authors:  A Kugaya; T Akechi; T Nakano; H Okamura; Y Shima; Y Uchitomi
Journal:  Support Care Cancer       Date:  1999-11       Impact factor: 3.603

4.  Suicide among patients with cancer cared for at home by palliative-care teams.

Authors:  C Ripamonti; A Filiberti; A Totis; F De Conno; M Tamburini
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

5.  Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin.

Authors:  K van Heeringen; M Zivkov
Journal:  Br J Psychiatry       Date:  1996-10       Impact factor: 9.319

Review 6.  The request to die: role for a psychodynamic perspective on physician-assisted suicide.

Authors:  P R Muskin
Journal:  JAMA       Date:  1998-01-28       Impact factor: 56.272

7.  A survey of antidepressant prescribing in the terminally ill.

Authors:  M Lloyd-Williams; T Friedman; N Rudd
Journal:  Palliat Med       Date:  1999-05       Impact factor: 4.762

8.  Will to live in the terminally ill.

Authors:  H M Chochinov; D Tataryn; J J Clinch; D Dudgeon
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

9.  High suicide mortality soon after diagnosis among cancer patients in central Italy.

Authors:  E Crocetti; S Arniani; S Acciai; A Barchielli; E Buiatti
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

10.  Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide.

Authors:  L Ganzini; W S Johnston; B H McFarland; S W Tolle; M A Lee
Journal:  N Engl J Med       Date:  1998-10-01       Impact factor: 91.245

View more
  12 in total

1.  Depression in terminally ill patients with cancer.

Authors:  Andy Huang; Dietmar Fuchs
Journal:  J R Soc Med       Date:  2002-10       Impact factor: 5.344

2.  Using item response theory (IRT) to reduce patient burden when assessing desire for hastened death.

Authors:  Elissa Kolva; Barry Rosenfeld; Ying Liu; Hayley Pessin; William Breitbart
Journal:  Psychol Assess       Date:  2016-06-09

3.  The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up.

Authors:  Carla I Ripamonti; Elena Bandieri; Maria Adelaide Pessi; Alice Maruelli; Loredana Buonaccorso; Guido Miccinesi
Journal:  Support Care Cancer       Date:  2013-11-26       Impact factor: 3.603

Review 4.  Depression--the hidden symptom in advanced cancer.

Authors:  Mari Lloyd-Williams
Journal:  J R Soc Med       Date:  2003-12       Impact factor: 18.000

Review 5.  What lies behind the wish to hasten death? A systematic review and meta-ethnography from the perspective of patients.

Authors:  Cristina Monforte-Royo; Christian Villavicencio-Chávez; Joaquin Tomás-Sábado; Vinita Mahtani-Chugani; Albert Balaguer
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

6.  Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan.

Authors:  Teruhiko Higuchi; Mike Briley
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

Review 7.  Physician-assisted suicide: a review of the literature concerning practical and clinical implications for UK doctors.

Authors:  Madelyn Hsiao-Rei Hicks
Journal:  BMC Fam Pract       Date:  2006-06-22       Impact factor: 2.497

8.  Incidence and risk factors for suicide and attempted suicide following a diagnosis of hematological malignancy.

Authors:  Malin Hultcrantz; Tobias Svensson; Åsa R Derolf; Sigurdur Y Kristinsson; Ebba K Lindqvist; Anders Ekbom; Fredrik Granath; Magnus Björkholm
Journal:  Cancer Med       Date:  2014-08-26       Impact factor: 4.452

9.  Suicides among Danish cancer patients 1971-1999.

Authors:  U Yousaf; M-Lm Christensen; G Engholm; H H Storm
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

10.  Development of a short form of the Spanish schedule of attitudes toward hastened death in a palliative care population.

Authors:  Cristina Monforte-Royo; Luis González-de Paz; Joaquín Tomás-Sábado; Barry Rosenfeld; Julia Strupp; Raymond Voltz; Albert Balaguer
Journal:  Qual Life Res       Date:  2016-09-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.